Mounjaro 2.5 mg Pen: What to Know About Your Starting Dose

Mounjaro (tirzepatide) is a once-weekly injectable medicine that acts on both GLP-1 and GIP receptors — pathways involved in appetite regulation and blood sugar control. According to information published on the electronic Medicines Compendium (eMC), tirzepatide is supplied as a pre-filled pen and is typically initiated at 2.5 mg once weekly before any dose adjustment is considered.

What "2.5 mg/0.5 ml" means

You may see your pen described as the Mounjaro 2.5 mg/0.5 ml pen — this simply means each 0.5 ml injection delivers 2.5 mg of tirzepatide. The pen is pre-filled and pre-set; you do not need to measure or draw up the dose yourself. If you have any questions about how your specific pen works, your prescriber, pharmacist, or the patient information leaflet that came with the pen are the right places to check.

The 2.5 mg to 5 mg step

After the initial period at 2.5 mg, many people move up to the 5 mg pen — but timing is entirely prescriber-led and depends on individual tolerance and response. The 2.5 mg dose is not considered a maintenance dose; it is a titration starting point. Never adjust your dose on your own: any step from 2.5 mg to 5 mg, or beyond, should be agreed with your prescriber. For a broader overview of how the dosing journey works across all strengths, see the Mounjaro dosing guide.

Common questions about the starting pen

Some people wonder whether the 2.5 mg dose "does anything" because appetite changes can feel subtle at this stage — that is normal. The starting dose is primarily about tolerability. Side effects such as nausea or digestive discomfort are commonly reported, particularly in the first week or two after starting or after a dose step. These often ease over time, but if they are severe or persistent, speak to your healthcare professional promptly.

If you are also curious about what the later pens involve, the 7.5 mg pen page covers that stage of the journey in more detail, and our page on getting started with Mounjaro 2.5 mg covers early-journey context.

Keeping an accurate record of every dose matters more than it might seem. When you log each injection — date, time, and dose strength — you build a clear picture that is genuinely useful when you speak to your prescriber about how things are going or whether a dose step is appropriate.

GLP Trackr's dose logging feature lets you record each weekly Mounjaro injection in seconds: the strength used, the date, and the time. As your journey progresses from the 2.5 mg pen toward higher strengths, every entry stays in your history so nothing gets lost. Pair that with the built-in dose reminder and you are far less likely to accidentally miss a weekly shot — something that is easy to do on a busy week.

If you do miss a dose, do not try to catch up or double up on your own. Log the missed injection in the app so you have an accurate record, then contact your prescriber or healthcare professional for guidance on what to do next — that decision is theirs to make, not ours.

GLP Trackr also lets you track how you feel alongside your doses: logging side effects such as nausea or fatigue at the 2.5 mg stage can reveal patterns over time and gives you something concrete to discuss at your next appointment. The app can even generate a summary report you can share with your prescriber. For a broader look at managing costs and access questions that often come up alongside dose changes, the Mounjaro cost and access overview has useful context.

Every dose decision — whether to stay at 2.5 mg, move to 5 mg, or anything beyond — should be made with your prescriber. GLP Trackr is here to help you track your journey, not to replace their guidance.

Ready to keep your weekly doses properly logged? Download GLP Trackr on the App Store or Google Play and start a free 7-day trial — your entire dosing history, from your very first 2.5 mg pen, in one place.